Affordable Access

The option value of innovative treatments for non-small cell lung cancer and renal cell carcinoma.

Authors
  • Thornton Snider, Julia
  • Batt, Katharine
  • Wu, Yanyu
  • Tebeka, Mahlet Gizaw
  • Seabury, Seth1
  • 1 University of Southern California, USC Schaeffer Center, 635 Downey Way, Los Angeles, CA 90089-3333. E-mail: [email protected]
Type
Published Article
Journal
The American journal of managed care
Publication Date
Oct 01, 2017
Volume
23
Issue
10
Identifiers
PMID: 29087638
Source
Medline
License
Unknown

Abstract

Option value is important when valuing therapies like nivolumab that extend life in a rapidly evolving area of care.

Report this publication

Statistics

Seen <100 times